Theoretical analysis reveals constraints on equivariant mappings in Weil pair spaces, highlighting that non-abelian carrier structures remain foundational inputs rather than derived outputs.
Let Φq,ρ be a morphism out of the Weil pair space Vq of Heis₃(Z/qZ), subject to three constraints imposed by the admissible projection Πadm: involution equivariance, quadratic compatibility with σₚₐᵢᵣ, and factorisation through the admissible quotient. The third gives unique real-linear factorisation through Q = Vq / Πadm and nothing more; a countermodel shows that the three together impose no equivariance. Write Ntrl for the neutral traceless part of the ambient observable space. Reaching Heff = Im\,Πadm ∩ Ntrl from that quotient and transferring O23's dimension count to it are one hypothesis, Im\,Πadm = Ntrl, assumed and derived nowhere. Under it and the spinor carrier supplied conditionally by paper O23, Heff su(2) and the representation action gives a canonical equivariant map su(2) → End(V_ρ) with one-dimensional complex intertwiner space, so an equivariant map is unique only up to a scalar that the quadratic constraint, a proportionality, does not fix. No non-zero su(2)-equivariant map reaches the fundamental representation from the adjoint, Homₛᵤ₍₂₎(3,2) = 0, excluding an equivariant adjoint-factorising realisation of O26 Hypothesis 4.4 but not every quotient-factorising linear lift; that hypothesis therefore remains open, and the su(2) identification remains supplied rather than derived. A second assumption makes the parity involution descend and act by Ad(g₀). Whether the canonical map satisfies the quadratic constraint is not settled: no result here makes the quotient map an isometry. Subject to it, δₚₐᵢᵣ would acquire a representation carrier in that sector; it does not acquire a derived interpretation of β^*, which has no native carrier on the Heisenberg substrate. Interpretation, not result: the non-abelian carrier is an input to this programme's representation layer, not an output of the constraints, which supply an exact calculus on it.
No takes yet. Share an insight, caveat, or question.
Jérôme Beau (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: